tirzepatide phase 3 study results A 3-year of in participants with obesity and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo. Full SURMOUNT-1 Tirzepatide weight-loss study shows promising

Metabolic benefits extend beyond weight loss, including improved insulin sensitivity, better lipid profiles, reduced inflammatory markers, and potential cardiovascular protection

We therefore proposed to make the following two-stage methodologic updates to 412.190(a)(2) and adding a new paragraph (a)(3))

Medical weight loss helps reduce overall body fat, while body sculpting treatments target specific areas for improved contour and definition

CJC-1295 without DAC includes specific amino acid substitutions at positions 2, 8, 15, and 27

Choose a physician to discuss this with who will take the time to help you decide whether it is truly right for you- someone who will review your health in detail, who understands the data and can explain it well, and who will monitor you appropriately while you are taking the medication